Regüeiferos, Justa Carmen Columbié
Luna, Taira Teresa Batista
Brooks, Soraida Cándida Acosta
Rodriguez, Maylet Planas
Matamoros, Larisa Zamora
Rodríguez, Beatríz Legrá
Fernández, Arnolis Poll
Bello, José Luis García
Pedrón, Arquímedes Montoya
González, Maraelys Morales
Garcia, Julio Cesar Núñez
Fonseca, Esmirna Cascaret
Cabrales, Luis Enrique Bergues
Article History
Received: 3 May 2022
Accepted: 9 August 2022
First Online: 23 August 2022
Declarations
:
: This study is approved at the hospital General Santiago “Dr. Juan Bruno Zayas Alfonso”, Santiago de Cuba, Cuba. The final protocol was approved by the Ethics committee (Current Controlled trials BIACANCER108823SC900–149; May 5, 2017) and Scientific Board (Resolution 189/2017; June 7, 2017) of the hospital Infantil Sur Antonio María Béguez César, Santiago de Cuba. Name of the register of this Pilot study is BIACANCER and its registration data is July 6, 2017 at the Universidad de Ciencias Médicas, Santiago de Cuba, Cuba. Date of enrolment of the first participant in this Pilot study is September 4, 2017. Written Informed Consent is obtained from each participant before entering the trial.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships. We declare no competing interests.